Erratum: Performance of an iterative two-stage Bayesian technique for population pharmacokinetic analysis of rich data sets (Pharmaceutical Research (December 2006) 23: 12, (2748-2759) DOI: 10.1007/s11095-006-9116-0);Performance of an Iterative Two-Stage Bayesian technique for population pharmacokinetic analysis of rich data sets

Pharmaceutical Research

Volumn 23, Issue 12, 2006, Pages 2748-2759

  Proost, Johannes H ^a,b   Eleveld, Douglas J ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

Bayesian analysis; Data analysis; Mixed effect modeling; Monte Carlo simulation; Population pharmacokinetics

Indexed keywords

RAPACURONIUM BROMIDE;

ACCURACY; ADULT; ARTICLE; BAYES THEOREM; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTINUOUS INFUSION; DISTRIBUTION VOLUME; DRUG CLEARANCE; EVALUATION; FEMALE; HUMAN; MALE; MATHEMATICAL ANALYSIS; MATHEMATICAL MODEL; MEASUREMENT; MONTE CARLO METHOD; NONLINEAR SYSTEM; PRIORITY JOURNAL;

EID: 33845353064     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-007-9261-0     Document Type: Erratum

References (16)

1. L. B. Sheiner and T. M. Ludden. Population pharmacokinetics/dynamics. Annu. Rev. Pharmacol. Toxicol. 32:185-209 (1992).
2. L. B. Sheiner, S. Beal, B. Rosenberg, and V. V. Marathe. Forecasting individual pharmacokinetics. Clin. Pharmacol. Ther. 26:294-305 (1979).
3. L. B. Sheiner and S. L. Beal. Bayesian individualization of pharmacokinetics: simple implementation and comparison with non-Bayesian methods. J. Pharm. Sci. 71:1344-1348 (1982).
4. R. W. Jelliffe, A. Schumitzky, D. Bayard, M. Milman, M. VanGuilder, X. Wang, F. Jiang, X. Barbaut, and P. Maire. Model-based, goal-oriented, individualized drug therapy. Clin. Pharmacokinet. 34:57-77 (1998).
5. A. Bustad, D. Terziivanov, R. Leary, R. Port, A. Schumitzky, and R. Jelliffe. Parametric and nonparametric population methodsVtheir comparative performance in analysing a clinical dataset and two Monte Carlo simulation studies. Clin. Pharmacokinet. 45:365-383 (2006).
6. G. Suzy. Monte Carlo Parametric Expectation Maximization (MC-PEM) method for analyzing population pharmacokinetic/ pharmacodynamic (PK/PD) data. Abstracts of the Annual Meeting of the Population Approach Group in Europe. ISSN 1871-6032 (available from URL http://www.page-meeting.org/ abstract=881) (2006).
7. J. L. Steimer, A. Mallet, J. L. Golmard, and J. F. Boisvieux. Alternative approaches to estimation of population pharmacokinetic parameters: comparison with the nonlinear mixed-effect model. Drug Metab. Rev. 15:265-292 (1984).
8. A. Racine-Poon and A. F. M. Smith. Population models D. A. Berry (ed.), Statistical Methodology in the Pharmaceutical Sciences, Marcel Dekker, New York, 1990, pp. 139-162. (Chapter 5).
9. F. Mentré and R. Gomeni. A two-step iterative algorithm for estimation in nonlinear mixed-effect models with an evaluation in population pharmacokinetics. J. Biopharm. Stat. 5:141-158 (1995).
10. J. E. Bennett and J. C. Wakefield. A comparison of a Bayesian population method with two methods as implemented in commercially available software. J. Pharmacokinet. Biopharm. 24:403-432 (1996).
11. D. J. Lunn, N. Best, A. Thomas, J. Wakefield, and D. Spiegelhalter. Bayesian analysis of population PK/PD model: general concepts and software. J. Pharmacokinet. Pharmacodyn. 29:271-307 (2002).
12. P. Girard and F. Mentré. A comparison of estimation methods in nonlinear mixed effects models using a blind analysis. Abstracts of the Annual Meeting of the Population Approach Group in Europe. ISSN 1871-6032 (available from URL http:// www.page-meeting.org/?abstract=834) (2005).
13. S. Schiere, J. H. Proost, M. Schuringa, and J. M. K. H. Wierda. Pharmacokinetics and pharmacokinetic-dynamic relationship between rapacuronium (Org 9487) and its 3-desacetyl metabolite (Org 9488). Anesth. Analg. 88:640-647 (1999).
14. W. H. Press, B. P. Flannery, S. A. Teukolsky, and W. T. Vetterling. Numerical Recipes, Cambridge University Press, Cambridge, 1986.
15. L. B. Sheiner and S. L. Beal. Some suggestions for measuring predictive performance. J. Pharmacokinet. Biopharm. 9:503-512 (1981).
16. J. H. Proost and D. K. F. Meijer. MW/Pharm, an integrated software package for drug dosage regimen calculation and therapeutic drug monitoring. Comput. Biol. Med. 22:155-163 (1992).